{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:25:25Z","timestamp":1707524725383},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,6]]},"DOI":"10.7759\/cureus.31159","type":"journal-article","created":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T14:07:52Z","timestamp":1667743672000},"source":"Crossref","is-referenced-by-count":0,"title":["Variability of Steroid Response Time in Polymyalgia Rheumatica: A Case Report"],"prefix":"10.7759","author":[{"given":"Carter","family":"Gay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colby","family":"Kihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"Oakley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arsh N","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.P.","family":"Akinsoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Developing classification criteria for polymyalgia rheumatica: comparison of views from an expert panel and wider survey","volume":"35","author":"Dasgupta B","year":"2008","unstructured":"Dasgupta B, Salvarani C, Schirmer M, Crowson CS, Maradit-Kremers H, Hutchings A, Matteson EL. Developing classification criteria for polymyalgia rheumatica: comparison of views from an expert panel and wider survey. J Rheumatol. 2008, 35:270-7.","journal-title":"J Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.5444","article-title":"Polymyalgia rheumatica and giant cell arteritis: a systematic review","volume":"315","author":"Buttgereit F","year":"2016","unstructured":"Buttgereit F, Dejaco C, Matteson EL, Dasgupta B. Polymyalgia rheumatica and giant cell arteritis: a systematic review. JAMA. 2016, 315:2442-58. 10.1001\/jama.2016.5444","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-014-2650-y","article-title":"Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy","volume":"35","author":"Mori S","year":"2016","unstructured":"Mori S, Koga Y. Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy. Clin Rheumatol. 2016, 35:1367-75. 10.1007\/s10067-014-2650-y","journal-title":"Clin Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.10-3-270","article-title":"Concise guidance: diagnosis and management of polymyalgia rheumatica","volume":"10","author":"Bhaskar D","year":"2010","unstructured":"Bhaskar D. Concise guidance: diagnosis and management of polymyalgia rheumatica. Clin Med. 2010, 10:270-4. 10.7861\/clinmedicine.10-3-270","journal-title":"Clin Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/art.22777","article-title":"Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica","volume":"57","author":"Hutchings A","year":"2007","unstructured":"Hutchings A, Hollywood J, Lamping DL, et al.. Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica. Arthritis Rheum. 2007, 57:803-9. 10.1002\/art.22777","journal-title":"Arthritis Rheum"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-eular.3434","article-title":"AB0596\u2005glucocorticoid-resistant polymyalgia rheumatica: clinical characterization and TOCILIZUMAB therapy","volume":"73","author":"Mori S","year":"2014","unstructured":"Mori S, Koga Y. AB0596\u2005glucocorticoid-resistant polymyalgia rheumatica: clinical characterization and TOCILIZUMAB therapy. Annals of the Rheumatic Diseases. 2014, 73:1002-3. 10.1136\/annrheumdis-2014-eular.3434","journal-title":"Annals of the Rheumatic Diseases"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/art.20901","article-title":"Acute-phase reactants and the risk of relapse\/recurrence in polymyalgia rheumatica: a prospective followup study","volume":"53","author":"Salvarani C","year":"2005","unstructured":"Salvarani C, Cantini F, Niccoli L, et al.. Acute-phase reactants and the risk of relapse\/recurrence in polymyalgia rheumatica: a prospective followup study. Arthritis Rheum. 2005, 53:33-8. 10.1002\/art.20901","journal-title":"Arthritis Rheum"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780401022","article-title":"Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica","volume":"40","author":"Gabriel SE","year":"1997","unstructured":"Gabriel SE, Sunku J, Salvarani C, O'Fallon WM, Hunder GG. Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica. Arthritis Rheum. 1997, 40:1873-8. 10.1002\/art.1780401022","journal-title":"Arthritis Rheum"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110851","article-title":"Adverse events during longterm low-dose glucocorticoid treatment of polymyalgia rheumatica: a retrospective study","volume":"39","author":"Mazzantini M","year":"2012","unstructured":"Mazzantini M, Torre C, Miccoli M, Baggiani A, Talarico R, Bombardieri S, Di Munno O. Adverse events during longterm low-dose glucocorticoid treatment of polymyalgia rheumatica: a retrospective study. J Rheumatol. 2012, 39:552-7. 10.3899\/jrheum.110851","journal-title":"J Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v3.i6.484","article-title":"Giant cell arteritis: current treatment and management","volume":"3","author":"Ponte C","year":"2015","unstructured":"Ponte C, Rodrigues AF, O'Neill L, Luqmani RA. Giant cell arteritis: current treatment and management. World J Clin Cases. 2015, 3:484-94. 10.12998\/wjcc.v3.i6.484","journal-title":"World J Clin Cases"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/116779-variability-of-steroid-response-time-in-polymyalgia-rheumatica-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:02Z","timestamp":1707508082000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/116779-variability-of-steroid-response-time-in-polymyalgia-rheumatica-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,6]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.31159","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,6]]}}}